Home / Moduli e servizi online / Farmacovigilanza / Reporting of cases of suspected adverse event for veterinary pharmacovigilance

Reporting of cases of suspected adverse event for veterinary pharmacovigilance


Italiano|English

La proceduraProcedure

Veterinary pharmacovigilance monitors the safety and efficacy of authorized veterinary medicinal products, constantly assessing their benefit/risk balance. To this end, the Ministry of Health, together with the Regional Pharmacovigilance Centers, promotes and makes available the means aimed at reporting any suspected adverse event, in particular:

a) any adverse (unfavorable and unintended) reaction in any animal to a veterinary medicinal product;

(b) any observation of a lack of efficacy of a veterinary medicinal product following its administration to an animal, whether or not in accordance with the summary of product characteristics;

c) any environmental incidents observed following the administration of a veterinary medicinal product to an animal;

d) any noxious reaction in humans exposed to a veterinary medicinal product;

e) any finding of a pharmacologically active substance or marker residue in a product of animal origin exceeding the maximum levels of residues established in accordance with Regulation (EC) No. 470/2009 after the set withdrawal period has been respected;

f) any suspected transmission of an infectious agent via a veterinary medicinal product;

g) any unfavorable and unintended reaction in an animal to a medicinal product for human use.

For reports, the doc, odt or online formats can be used (see modules section).

The Ministry of Health and/or the Regional Pharmacovigilance Centers submit a reply to the reporter at the email address (not CEM address) indicated in the reporting form.

 

Chi può richiederloWho can apply?

Veterinarians and other professionals in the sector while carrying out their activities and anyone who has reason to suspect an adverse event resulting from the use of a veterinary medicinal product.

 

 

Cosa serve per richiederloWhat do I need?

 

Suspected adverse event reporting form.

ModuliApplication form and guidelines

Come si presenta la richiestaHow can I apply?

  • Certified email (PEC)
    Certified email: dgsa@postacert.sanita.it
    Email subject: MDV-FMV-PSK - Suspected adverse event reporting form
    Further instructions: Only for forms in online format. The downloaded file must be saved and sent as an attachment as it is, without being modified and scanned.
  • Email
    Email of the receiving office: farmacovigilanzavet@sanita.it
    Email subject: MDV-FMV-PSK - Suspected adverse event reporting form
    Further instructions: Only for forms in doc format and odt format. The documents sent by traditional email must be signed digitally.

Quanto tempo ci vuoleHow long does it take?

Thirty (30) minutes/one (1) hour.

 

Quanto costaHow much does it cost?

not present

Come viene comunicato l'esitoHow do I know the outcome?

not present

Dove viene pubblicato l'esitoOutcome Publication

not present

NormativaRelevant law

Go to Trovanormesalute

ContattiContact us

  • Referent Name: Rita Quondam Giandomenico
    Address: Viale Giorgio Ribotta, 5 - 00144 Roma
    Email: r.quondam@sanita.it

Ufficio responsabile del procedimentoReferent Office for Legal proceedings

Direzione Generale della Sanità Animale e dei Farmaci veterinari (DGSAF)
Ufficio 4 - Medicinali veterinari

FAQQ&A

not present

TemiThematic site

Ufficio responsabile del procedimentoOffice


Data ultimo aggiornamento: 03 maggio 2023


.